Caseware UK (AP4) 2024.0.164 2024.0.164 2024-12-312024-12-31falsetruemanufacture of beds and furniture.true124false572023-07-02falsetrue 08529305 2023-07-02 2024-12-31 08529305 2022-06-26 2023-07-01 08529305 2024-12-31 08529305 2023-07-01 08529305 2022-06-26 08529305 1 2023-07-02 2024-12-31 08529305 1 2022-06-26 2023-07-01 08529305 1 2023-07-02 2024-12-31 08529305 d:Exceptional 2023-07-02 2024-12-31 08529305 d:Exceptional 2022-06-26 2023-07-01 08529305 e:Director1 2023-07-02 2024-12-31 08529305 e:Director2 2023-07-02 2024-12-31 08529305 e:Director3 2023-07-02 2024-12-31 08529305 e:RegisteredOffice 2023-07-02 2024-12-31 08529305 d:PlantMachinery 2023-07-02 2024-12-31 08529305 d:PlantMachinery 2024-12-31 08529305 d:PlantMachinery 2023-07-01 08529305 d:PlantMachinery d:OwnedOrFreeholdAssets 2023-07-02 2024-12-31 08529305 d:PlantMachinery d:LeasedAssetsHeldAsLessee 2023-07-02 2024-12-31 08529305 d:MotorVehicles 2023-07-02 2024-12-31 08529305 d:MotorVehicles 2024-12-31 08529305 d:MotorVehicles 2023-07-01 08529305 d:MotorVehicles d:OwnedOrFreeholdAssets 2023-07-02 2024-12-31 08529305 d:MotorVehicles d:LeasedAssetsHeldAsLessee 2023-07-02 2024-12-31 08529305 d:FurnitureFittings 2023-07-02 2024-12-31 08529305 d:FurnitureFittings 2024-12-31 08529305 d:FurnitureFittings 2023-07-01 08529305 d:FurnitureFittings d:OwnedOrFreeholdAssets 2023-07-02 2024-12-31 08529305 d:FurnitureFittings d:LeasedAssetsHeldAsLessee 2023-07-02 2024-12-31 08529305 d:OwnedOrFreeholdAssets 2023-07-02 2024-12-31 08529305 d:LeasedAssetsHeldAsLessee 2023-07-02 2024-12-31 08529305 d:CurrentFinancialInstruments 2024-12-31 08529305 d:CurrentFinancialInstruments 2023-07-01 08529305 d:Non-currentFinancialInstruments 2024-12-31 08529305 d:Non-currentFinancialInstruments 2023-07-01 08529305 d:CurrentFinancialInstruments d:WithinOneYear 2024-12-31 08529305 d:CurrentFinancialInstruments d:WithinOneYear 2023-07-01 08529305 d:Non-currentFinancialInstruments d:AfterOneYear 2024-12-31 08529305 d:Non-currentFinancialInstruments d:AfterOneYear 2023-07-01 08529305 f:UnitedKingdom 2023-07-02 2024-12-31 08529305 f:UnitedKingdom 2022-06-26 2023-07-01 08529305 f:RestEuropeOutsideUK 2023-07-02 2024-12-31 08529305 f:RestEuropeOutsideUK 2022-06-26 2023-07-01 08529305 f:RestWorldOutsideUK 2023-07-02 2024-12-31 08529305 f:RestWorldOutsideUK 2022-06-26 2023-07-01 08529305 d:ShareCapital 2023-07-02 2024-12-31 08529305 d:ShareCapital 2024-12-31 08529305 d:ShareCapital 2022-06-26 2023-07-01 08529305 d:ShareCapital 2023-07-01 08529305 d:ShareCapital 2022-06-26 08529305 d:RetainedEarningsAccumulatedLosses 2023-07-02 2024-12-31 08529305 d:RetainedEarningsAccumulatedLosses 2024-12-31 08529305 d:RetainedEarningsAccumulatedLosses 2022-06-26 2023-07-01 08529305 d:RetainedEarningsAccumulatedLosses 2023-07-01 08529305 d:RetainedEarningsAccumulatedLosses 2022-06-26 08529305 d:FinancialAssetsDesignatedFairValueThroughProfitOrLoss 2024-12-31 08529305 d:FinancialAssetsDesignatedFairValueThroughProfitOrLoss 2023-07-01 08529305 d:FinancialLiabilitiesFairValueThroughProfitOrLoss d:ListedExchangeTraded 2024-12-31 08529305 d:FinancialLiabilitiesFairValueThroughProfitOrLoss d:ListedExchangeTraded 2023-07-01 08529305 d:AcceleratedTaxDepreciationDeferredTax 2024-12-31 08529305 d:AcceleratedTaxDepreciationDeferredTax 2023-07-01 08529305 e:OrdinaryShareClass1 2023-07-02 2024-12-31 08529305 e:OrdinaryShareClass1 2024-12-31 08529305 e:FRS102 2023-07-02 2024-12-31 08529305 e:Audited 2023-07-02 2024-12-31 08529305 e:FullAccounts 2023-07-02 2024-12-31 08529305 e:PrivateLimitedCompanyLtd 2023-07-02 2024-12-31 08529305 d:WithinOneYear 2024-12-31 08529305 d:WithinOneYear 2023-07-01 08529305 d:BetweenOneFiveYears 2024-12-31 08529305 d:BetweenOneFiveYears 2023-07-01 08529305 d:HirePurchaseContracts d:WithinOneYear 2024-12-31 08529305 d:HirePurchaseContracts d:WithinOneYear 2023-07-01 08529305 d:HirePurchaseContracts d:BetweenOneFiveYears 2024-12-31 08529305 d:HirePurchaseContracts d:BetweenOneFiveYears 2023-07-01 08529305 4 2023-07-02 2024-12-31 08529305 d:PlantMachinery d:LeasedAssetsHeldAsLessee 2024-12-31 08529305 d:PlantMachinery d:LeasedAssetsHeldAsLessee 2023-07-01 08529305 d:LeasedAssetsHeldAsLessee 2024-12-31 08529305 d:LeasedAssetsHeldAsLessee 2023-07-01 08529305 g:PoundSterling 2023-07-02 2024-12-31 iso4217:GBP xbrli:shares xbrli:pure

Registered number: 08529305









HYPNOS CONTRACT BEDS LIMITED









ANNUAL REPORT AND FINANCIAL STATEMENTS

FOR THE 18 MONTH PERIOD ENDED 31 DECEMBER 2024

 
HYPNOS CONTRACT BEDS LIMITED
 
 
COMPANY INFORMATION


Directors
J P G Keen 
D J Baldry 
C J Hayfield 




Registered number
08529305



Registered office
Hypnos Limited
Longwick Road

Princes Risborough

Buckinghamshire

HP27 9RS




Independent auditors
Barnes Roffe Audit Limited
Chartered Accountants & Statutory Auditors

3 Brook Business Centre

Cowley Mill Road

Uxbridge

Middlesex

UB8 2FX





 
HYPNOS CONTRACT BEDS LIMITED
 

CONTENTS



Page
Strategic report
1 - 5
Directors' report
6 - 7
Independent auditors' report
8 - 12
Statement of comprehensive income
13
Statement of financial position
14 - 15
Statement of changes in equity
16
Notes to the financial statements
17 - 33


 
HYPNOS CONTRACT BEDS LIMITED
 
 
STRATEGIC REPORT
FOR THE 18 MONTH PERIOD ENDED 31 DECEMBER 2024

Introduction
 
The directors present the strategic report for the 18 month period ended 31 December 2024.
Company overview
Keen & Toms Holdings Limited is the parent company of several entities (“the Group”) that collectively trade under the name Hypnos. Established in Buckinghamshire in 1904, the fifth-generation family-run business manufactures handcrafted, pocket spring beds and upholstery using natural and responsibly sourced materials. The Group supplies retail and hospitality clients in the UK and internationally, and has held a Royal Warrant since 1929.
As a pioneer in sustainable and ethical bed making, Hypnos is focused on delivering comfort with integrity for the well-being of people and the planet.
Hypnos is a proud partner of the Eden Project, holder of the Planet Mark and has been certified Carbon Neutral by Planet Mark since 2011.

Business review and Future Developments
 
Building a secure foundation for future growth
2024 was a significant year in the Group’s history, marking the 120th anniversary as well as the completion of a two-year change programme to place the business in the strongest possible position for its next centenary.
Initiated in 2022, Project Rightsize involved a comprehensive strategic review to refocus the business and develop capabilities to form a robust platform for long-term success. The Group invested £1.7M to achieve its strategic goals. key outcomes of the change programme including:
 
New Board and leadership structure, aligned to company objectives.
Closure of the loss-leading venture into two-man furniture delivery services, including the exit of three operating sites.  
Consolidation of Group buildings from six sites to one wholly owned facility, and headcount reduction from 519 to circa 290.
Refocused sales, finance and operations functions and processes, enhancing efficiency, productivity, service, and financial position.
Investment of circa £1m in new ERP infrastructure development to integrate workflows, enable consolidated data and improve reporting. 
Appointment of a new transport and logistics partner, generating cost savings and supporting the Group’s CO2 reduction ambitions.
Along with international licencing and manufacturing partners.  

Even during this period of significant change and against a backdrop of macroeconomic uncertainty, the business continued to launch innovative new products and maintained strong commercial relationships with retail and hospitality key accounts, as well as with independent retailers. 
The Group’s unwavering commitment to excellence, sustainability, and the finest British craftsmanship was recognised with the granting of a Royal Warrant by His Majesty King Charles III, adding to a proud history of supplying the Royal Households for almost a century. 
The successful delivery of the change programme, coupled with the strength of the underlying business, is testament to the dedication of the Group’s skilled and committed people and the effectiveness of its empowered, ambitious, and engaged culture. 
 
Page 1

 
HYPNOS CONTRACT BEDS LIMITED
 

STRATEGIC REPORT (CONTINUED)
FOR THE 18 MONTH PERIOD ENDED 31 DECEMBER 2024

Looking ahead with confidence
Trading in the first 8 months of the 2025 financial year has been robust, with operating profits exceeding those recorded over the preceding 18 months. The strong cash generation is clear evidence of the business’ resilience and growth potential, which are supported by the new 5-year facility agreed in April 2025.
With firm foundations in place, the Board is confident that the Group is well positioned to achieve its strategic ambitions and deliver long-term, sustainable success.
Towards the end of the reporting period, Hypnos Contract Beds Limited became a sales and distribution business, only maintaining its focus on large premium hospitality groups and luxury hotel contracts for the UK and international export markets. Following a decision to consolidate manufacturing at the Princes Risborough facility of sister company Hypnos Limited, the lease on the Castle Donington site was not renewed, and manufacturing operations ceased in March  2024.
This reduction in fixed costs has placed Hypnos Contract Beds in an excellent position for growth, maximising access to the Group’s facilities, knowledge and team.


Section 172 statement
Statement by the directors in performance of their statutory duties in accordance with s172(1) of the Companies Act 2006.
In accordance with section 172 of the Companies Act 2006, each director acts in a way they consider, in good faith, would most likely promote the success of the company for the benefit of its members as a whole.
The Board ensures that all decisions are taken for the long term, and collectively and individually aims to always uphold the highest standard of conduct. Similarly, the Board acknowledges that the business can only grow and prosper over the long term if it understands and respects the views and needs of the company’s shareholders, customers, employees, suppliers and other stakeholders to whom it is accountable, as well as the environment in which the business operates.
The CEO, together with the Group Managing Director, sets the agenda for each Board meeting to ensure that requirements of section 172 are always met and considered through a combination of the following:
 
Board papers ensure that stakeholder factors are addressed, where relevant.
Health & Safety performance is always the first item on the agenda. Other standing agenda points include updates on operational and financial performance against objectives, including progress against budget and cash position.
At the time of undertaking the annual budgeting exercise, the Board considers the strategic direction of the business and how this fulfils the Group’s long-term objectives.

The Board recognises that its strategic decisions can have long-term implications for the business and its stakeholders, and these implications are assessed as a core part of the decision-making process.
Employee Engagement
Attraction and retention of skilled people are core to the success of the Group. Employee engagement is extremely important to the Board, and there are several workforce engagement mechanisms in place:
 
Employees are kept informed of performance, strategy and short-term outlook through regular news briefings and updates from members of the Board, including Town Hall presentations by the Group Managing Director to the whole company.
Employee engagement surveys are undertaken, with results and proposed action plans shared with the Board.
Page 2

 
HYPNOS CONTRACT BEDS LIMITED
 

STRATEGIC REPORT (CONTINUED)
FOR THE 18 MONTH PERIOD ENDED 31 DECEMBER 2024

The Workplace Council, made up of employees and hosted by a Board member, meets monthly provides a valuable source of insights and ideas.
Pay rates and benefit structures are reviewed regularly to ensure every colleague receives fair pay.
Employee-related topics including staff welfare, workplace morale, succession planning and promoting diverse recruitment are regular agenda items at monthly main Board meetings. 
The group operates a Valuing Diversity and Dignity at Work Policy.
 
Having regard to the need to foster the company’s business relationships with suppliers, customers and others
Suppliers
The Board recognises the importance of fostering long-term, collaborative relationships with key suppliers to support the Group’s growth, innovation and sustainability, while balancing value for shareholders to ensure mutual benefit. 
The Group is proud to have pioneered certifications and standards in the industry and supply chain, including the Responsible Wool Standard (RWS), which focuses on improved land management and animal welfare for British farms and farmers, and the Red Tractor assured farm standards. Hypnos has supported the Woolkeepers® initiative since 2019 to achieve these standards whilst providing British farmers a fair price for their wool. 2024 saw the RWS standard applied to 60 UK farms. The Group Managing Director and other members of the senior management team (SMT) work with suppliers on projects including New Product Development, implementing new standards, and sharing experience from key initiatives. Third party guidance is introduced as needed, for example from Planet Mark, to aid continuous development programmes to benefit product, service and sustainability goals. This work is reported on and reviewed at Board and SMT meetings. 
Customers
Customer obsession is one of the Group’s core values, alongside sustainable innovation, responsibility, and integrity. Customer and consumer sentiment is reflected in sales performance, which is reviewed regularly by the Board. Senior management also provides updates to the Board on their perceptions of customer sentiment and the market outlook. 
Customer interests are considered in strategic decision-making across key areas, including product portfolio changes, brand image and reputation, maintaining an innovative approach to sustainability, development of IT systems to facilitate doing business with the Group, and investment in marketing.
Credit facility providers and credit reference agencies
Alongside the Group Managing Director, the Group Finance Director is responsible for managing the relationships with banks and credit rating agencies, and for the Group’s cash, debt management and financing activities. The Group Finance Director provides regular reports to the Board on these activities, including plans to ensure appropriate access to debt capital and monitoring the headroom of credit facilities.
Having regard to the impact of the company’s operations on the community and the environment
Operating sustainably and responsibly is at the heart of the Group’s values and operations, evidenced by ISO 14001 certification and a proactive approach to reducing emissions. More information can be found in the Streamlined Energy and Carbon Report.
The Group’s 6-year relationship with the Eden Project has influenced multiple areas of the business including sourcing, and linking to local conservation and community. 
In addition to encouraging colleagues’ fundraising and volunteering initiatives, each year the Group supports selected national and local charity partners with monetary donations, volunteering and driving awareness.
Page 3

 
HYPNOS CONTRACT BEDS LIMITED
 

STRATEGIC REPORT (CONTINUED)
FOR THE 18 MONTH PERIOD ENDED 31 DECEMBER 2024

Beneficiaries have included Chiltern Rangers, The Furniture Makers’ Company benevolent fund, Pace Centre, and Youth Concern.

Principal risks and uncertainties
 
The Board has overall responsibility for the management of risk and the identification of principal risks that may affect achievement of the Group’s strategic objectives. Risk management is an integral part of decision-making, with risks and mitigations evaluated regularly. The principal [financial and liquidity] risks identified by the Group are outlined below.
The Group’s primary financial instruments are trade creditors, cash at bank, overdrafts and inter-company balances. These arise directly from the Group’s trading activities and management have implemented procedures to monitor and control the liquidity and credit risks relating to the Group’s financial affairs.
Through Project Rightsize, the Group utilised its cash and cash equivalents to execute the accelerated change programme, funding short-term impact costs strategically over the reporting period.
Credit risk
The Group has a confidential invoice discounting facility, a specific credit insurance policy to cover credit risk, and a policy to actively review client credit scores.
Bad debts remain low, and credit control processes are reviewed regularly to ensure they are appropriate for the Group’s risk appetite
Cash flow risk
The Group operates a detailed cash flow forecasting process and proactively seeks appropriate funding to support its ambitions. As the Group has significantly reduced its fixed costs this risk is considered to be minimal.
 
Price risk
The Group is not significantly exposed to fluctuations in commodity prices, and the diversity of its supplier base would help minimise any potential impact.
Foreign exchange risk
The Group does not use derivative financial instruments and instead relies on a natural hedge between receivables and payables in foreign currencies.
 
Page 4

 
HYPNOS CONTRACT BEDS LIMITED
 

STRATEGIC REPORT (CONTINUED)
FOR THE 18 MONTH PERIOD ENDED 31 DECEMBER 2024


Financial key performance indicators
The directors use a variety of measures to assess the performance of the company. The major measures are operational profitability, stock-turn ratio and revenue growth.



 
18 month 
period ended
 
31 December 
2024
53 week 
period ended 
1 July 
2023


Variance

£
£
%
Revenue
14,269,268
20,096,281
(29%)
Operating (loss)/profit
(1,968,505)
130,531
(1608%)
Stock turnover ratio
43
19
126%



This report was approved by the board on 30 September 2025 and signed on its behalf.



D J Baldry
Director

Page 5

 
HYPNOS CONTRACT BEDS LIMITED
 
 
 
DIRECTORS' REPORT
FOR THE 18 MONTH PERIOD ENDED 31 DECEMBER 2024

The directors present their report and the financial statements for the 18 month period ended 31 December 2024.

Directors' responsibilities statement

The directors are responsible for preparing the Strategic report, the Directors' report and the financial statements in accordance with applicable law and regulations.
 
Company law requires the directors to prepare financial statements for each financial year. Under that law the directors have elected to prepare the financial statements in accordance with applicable law and United Kingdom Accounting Standards (United Kingdom Generally Accepted Accounting Practice), including Financial Reporting Standard 102 ‘The Financial Reporting Standard applicable in the UK and Republic of Ireland'. Under company law the directors must not approve the financial statements unless they are satisfied that they give a true and fair view of the state of affairs of the Company and of the profit or loss of the Company for that period.

 In preparing these financial statements, the directors are required to:


select suitable accounting policies for the Company's financial statements and then apply them consistently;

make judgments and accounting estimates that are reasonable and prudent;

state whether applicable UK Accounting Standards have been followed, subject to any material departures disclosed and explained in the financial statements;

prepare the financial statements on the going concern basis unless it is inappropriate to presume that the Company will continue in business.

The directors are responsible for keeping adequate accounting records that are sufficient to show and explain the Company's transactions and disclose with reasonable accuracy at any time the financial position of the Company and to enable them to ensure that the financial statements comply with the Companies Act 2006They are also responsible for safeguarding the assets of the Company and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.

Results and dividends

The loss for the 18 month period, after taxation, amounted to £1,969,112 (53 week ending 1 July 2023  profit £129,301). 

The company did not declare dividends in the 18 month period (53 week ending 1 July 2023 - £Nil).

Directors

The directors who served during the 18 month period were:

J P G Keen 
D J Baldry 

C J Hayfield was appointed as a director on 6 March 2025.

Page 6

 
HYPNOS CONTRACT BEDS LIMITED
 
 
 
DIRECTORS' REPORT (CONTINUED)
FOR THE 18 MONTH PERIOD ENDED 31 DECEMBER 2024

Matters covered in the Strategic Report

The company has chosen, in accordance with section 414C of the Company's Act 2006, to set out the following information which would otherwise be required to be contained in the director's report within strategic report:
i) Business review and future developments; and
ii) Likely financial risk management objective and policies; and key performance indicators.

Disclosure of information to auditors

Each of the persons who are directors at the time when this Directors' report is approved has confirmed that:
 
so far as the director is aware, there is no relevant audit information of which the Company's auditors are unaware, and

the director has taken all the steps that ought to have been taken as a director in order to be aware of any relevant audit information and to establish that the Company's auditors are aware of that information.

Post balance sheet events

Subsequent to the year end, the company refinanced its existing borrowing facilities. The refinancing replaced
the previous loan agreement with new facilities on improved terms. This event occurred after the year end and
does not affect the amounts recognised in the financial statements.
There are no other subsequent events that require disclosure or adjustments to the financial statements.

Auditors

After the year end Barnes Roffe LLP resigned as auditors due to the transfer of its audit business and its successor Barnes Roffe Audit Limited was appointed by the directors under s485 Companies Act 2006.

This report was approved by the board on 30 September 2025 and signed on its behalf.
 





D J Baldry
Director

Page 7

 
HYPNOS CONTRACT BEDS LIMITED
 
 
 
INDEPENDENT AUDITORS' REPORT TO THE MEMBERS OF HYPNOS CONTRACT BEDS LIMITED
 

Opinion


We have audited the financial statements of Hypnos Contract Beds Limited (the 'Company') for the 18 month period ended 31 December 2024, which comprise the Statement of comprehensive income, the Statement of financial position, the Statement of changes in equity and the related notes, including a summary of significant accounting policiesThe financial reporting framework that has been applied in their preparation is applicable law and United Kingdom Accounting Standards, including Financial Reporting Standard 102 ‘The Financial Reporting Standard applicable in the UK and Republic of Ireland' (United Kingdom Generally Accepted Accounting Practice).


In our opinion the financial statements:


give a true and fair view of the state of the Company's affairs as at 31 December 2024 and of its loss for the 18 month period then ended;
have been properly prepared in accordance with United Kingdom Generally Accepted Accounting Practice; and
have been prepared in accordance with the requirements of the Companies Act 2006.


Basis for opinion


We conducted our audit in accordance with International Standards on Auditing (UK) (ISAs (UK)) and applicable law. Our responsibilities under those standards are further described in the Auditors' responsibilities for the audit of the financial statements section of our report. We are independent of the Company in accordance with the ethical requirements that are relevant to our audit of the financial statements in the United Kingdom, including the Financial Reporting Council's Ethical Standard and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.


Conclusions relating to going concern


In auditing the financial statements, we have concluded that the directors' use of the going concern basis of accounting in the preparation of the financial statements is appropriate.


Based on the work we have performed, we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the Company's ability to continue as a going concern for a period of at least twelve months from when the financial statements are authorised for issue.


Our responsibilities and the responsibilities of the directors with respect to going concern are described in the relevant sections of this report.


Page 8

 
HYPNOS CONTRACT BEDS LIMITED
 
 
 
INDEPENDENT AUDITORS' REPORT TO THE MEMBERS OF HYPNOS CONTRACT BEDS LIMITED (CONTINUED)


Other information


The other information comprises the information included in the Annual Report other than the financial statements and our Auditors' report thereon. The directors are responsible for the other information contained within the Annual ReportOur opinion on the financial statements does not cover the other information and, except to the extent otherwise explicitly stated in our report, we do not express any form of assurance conclusion thereon. Our responsibility is to read the other information and, in doing so, consider whether the other information is materially inconsistent with the financial statements or our knowledge obtained in the course of the audit, or otherwise appears to be materially misstated. If we identify such material inconsistencies or apparent material misstatements, we are required to determine whether this gives rise to a material misstatement in the financial statements themselves. If, based on the work we have performed, we conclude that there is a material misstatement of this other information, we are required to report that fact.


We have nothing to report in this regard.


Opinion on other matters prescribed by the Companies Act 2006
 

In our opinion, based on the work undertaken in the course of the audit:


the information given in the Strategic report and the Directors' report for the financial 18 month period for which the financial statements are prepared is consistent with the financial statements; and
the Strategic report and the Directors' report have been prepared in accordance with applicable legal requirements.


Matters on which we are required to report by exception
 

In the light of the knowledge and understanding of the Company and its environment obtained in the course of the audit, we have not identified material misstatements in the Strategic report or the Directors' report.


We have nothing to report in respect of the following matters in relation to which the Companies Act 2006 requires us to report to you if, in our opinion:


adequate accounting records have not been kept, or returns adequate for our audit have not been received from branches not visited by us; or
the financial statements are not in agreement with the accounting records and returns; or
certain disclosures of directors' remuneration specified by law are not made; or
we have not received all the information and explanations we require for our audit.


Page 9

 
HYPNOS CONTRACT BEDS LIMITED
 
 
 
INDEPENDENT AUDITORS' REPORT TO THE MEMBERS OF HYPNOS CONTRACT BEDS LIMITED (CONTINUED)


Responsibilities of directors
 

As explained more fully in the Directors' responsibilities statement set out on page 6, the directors are responsible for the preparation of the financial statements and for being satisfied that they give a true and fair view, and for such internal control as the directors determine is necessary to enable the preparation of financial statements that are free from material misstatement, whether due to fraud or error.


In preparing the financial statements, the directors are responsible for assessing the Company's ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless the directors either intend to liquidate the Company or to cease operations, or have no realistic alternative but to do so.
Auditors' responsibilities for the audit of the financial statements
 
Our objectives are to obtain reasonable assurance about whether the financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue an Auditors' report that includes our opinion. Reasonable assurance is a high level of assurance, but is not a guarantee that an audit conducted in accordance with ISAs (UK) will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these financial statements.
Irregularities, including fraud, are instances of non-compliance with laws and regulations. We design procedures in line with our responsibilities, outlined above, to detect material misstatements in respect of irregularities, including fraud. The extent to which our procedures are capable of detecting irregularities, including fraud is detailed below.
Our approach to identifying and assessing the risks of material misstatement in respect of irregularities, including fraud and non-compliance with law and regulations, was as follows:
 
The engagement partner ensured that the engagement team collectively had the appropriate competence, capabilities and skills to identify or recognise non-compliance with applicable laws and regulations;
We identified the laws and regulations applicable to the company through discussion with directors and other management, and from our commercial knowledge and experience of the relevant sector;
The specific laws and regulations which we considered may have a direct material effect on the financial statements or the operations of the company, are as follows: 
i) Companies Act 2006
ii) FRS 102
iii) Tax legislation
iv) Employment legislation
v) Health and safety legislation
 
We assessed the extent of compliance with the laws and regulations identified above through making enquiries of management and reviewing supporting evidence where applicable; and 
Laws and regulations were communicated within the audit team at the planning meeting, and during the audit as any further laws and regulation were identified. The audit team remained alert to instances of non-compliance throughout the audit.
Page 10

 
HYPNOS CONTRACT BEDS LIMITED
 
 
 
INDEPENDENT AUDITORS' REPORT TO THE MEMBERS OF HYPNOS CONTRACT BEDS LIMITED (CONTINUED)


 

We assessed the susceptibility of the company’s financial statements to material misstatement, including obtaining an understanding of how fraud might occur by: 

Making enquiries of management as to where they consider there was susceptibility to fraud and their knowledge of actual suspected and alleged fraud;
Considering the internal controls in place to mitigate risks of fraud and non-compliance with laws and regulations;
Reviewing the financial statements and testing the disclosures against supporting documentation;
Performing analytical procedures to identify any unusual or unexpected trends or anomalies;
Inspecting and testing journal entries to identify unusual or unexpected transactions;
Assessing whether judgement and assumptions made in determining significant accounting estimates, were indicative of management bias; and
Investigating the rationale behind significant transactions, or transactions that are unusual or outside the company’s usual course of business.
 
The areas that we identified as being susceptible to misstatement through fraud were:
 
Management bias in the estimates and judgements made;
Management override of controls; and
Posting of unusual journals or transactions.


Because of the inherent limitations of an audit, there is a risk that we will not detect all irregularities, including those leading to a material misstatement in the financial statements or non-compliance with regulation. This risk increases the more that compliance with a law or regulation is removed from the events and transactions reflected in the financial statements, as we will be less likely to become aware of instances of non-compliance. The risk is also greater regarding irregularities occurring due to fraud rather than error, as fraud involves intentional concealment, forgery, collusion, omission or misrepresentation.


A further description of our responsibilities for the audit of the financial statements is located on the Financial Reporting Council's website at: www.frc.org.uk/auditorsresponsibilities. This description forms part of our Auditors' report.


Page 11

 
HYPNOS CONTRACT BEDS LIMITED
 
 
 
INDEPENDENT AUDITORS' REPORT TO THE MEMBERS OF HYPNOS CONTRACT BEDS LIMITED (CONTINUED)


Use of our report
 

This report is made solely to the Company's members, as a body, in accordance with Chapter 3 of Part 16 of the Companies Act 2006Our audit work has been undertaken so that we might state to the Company's members those matters we are required to state to them in an Auditors' report and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the Company and the Company's members, as a body, for our audit work, for this report, or for the opinions we have formed.





Nigel Goodman (Senior statutory auditor)
for and on behalf of
Barnes Roffe Audit Limited
Chartered Accountants & Statutory Auditors
3 Brook Business Centre
Cowley Mill Road
Uxbridge
Middlesex
UB8 2FX

 
Date: 
30 September 2025
Page 12

 
HYPNOS CONTRACT BEDS LIMITED
 
 
STATEMENT OF COMPREHENSIVE INCOME
FOR THE 18 MONTH PERIOD ENDED 31 DECEMBER 2024

18 month period ended
31 December
53 week period ended
1 July
2024
2023
Note
£
£

  

Turnover
 4 
14,269,268
20,096,281

Cost of sales
  
(9,093,635)
(12,575,245)

Gross profit
  
5,175,633
7,521,036

Distribution costs
  
(4,373,775)
(6,225,166)

Administrative expenses
  
(1,301,944)
(1,274,392)

Exceptional administrative expenses
 12 
(1,468,419)
(150,947)

Other operating income
 5 
-
260,000

Operating (loss)/profit
 6 
(1,968,505)
130,531

Interest payable and similar expenses
 10 
(607)
(1,230)

(Loss)/profit before tax
  
(1,969,112)
129,301

(Loss)/profit for the financial period
  
(1,969,112)
129,301

Total comprehensive income for the period
  
(1,969,112)
129,301

The notes on pages 17 to 33 form part of these financial statements.

Page 13

 
HYPNOS CONTRACT BEDS LIMITED
REGISTERED NUMBER: 08529305

STATEMENT OF FINANCIAL POSITION
AS AT 31 DECEMBER 2024


31 December

1 July

2024

2023
Note
£
£
£
£

Fixed assets
  

Tangible assets
 13 
-
240,699

  
-
240,699

Current assets
  

Stocks
 14 
-
424,843

Debtors: amounts falling due within one year
 15 
2,217,457
2,369,504

Cash at bank and in hand
 16 
1,174,598
441,942

  
3,392,055
3,236,289

Creditors: amounts falling due within one year
 17 
(7,810,203)
(5,911,984)

Net current liabilities
  
 
 
(4,418,148)
 
 
(2,675,695)

Total assets less current liabilities
  
(4,418,148)
(2,434,996)

Creditors: amounts falling due after more than one year
 18 
(3,440)
(17,480)

Provisions for liabilities
  

Deferred tax
 21 
(56,028)
(56,028)

  
 
 
(56,028)
 
 
(56,028)

Net liabilities
  
(4,477,616)
(2,508,504)


Capital and reserves
  

Called up share capital 
 22 
1
1

Profit and loss account
 23 
(4,477,617)
(2,508,505)

  
(4,477,616)
(2,508,504)


Page 14

 
HYPNOS CONTRACT BEDS LIMITED
REGISTERED NUMBER: 08529305
    
STATEMENT OF FINANCIAL POSITION (CONTINUED)
AS AT 31 DECEMBER 2024

The financial statements were approved and authorised for issue by the board and were signed on its behalf on 30 September 2025.




J P G Keen
D J Baldry
Director
Director

The notes on pages 17 to 33 form part of these financial statements.

Page 15

 
HYPNOS CONTRACT BEDS LIMITED
 

STATEMENT OF CHANGES IN EQUITY
FOR THE 18 MONTH PERIOD ENDED 31 DECEMBER 2024


Called up share capital
Profit and loss account
Total equity

£
£
£

At 2 July 2023
1
(2,508,505)
(2,508,504)


Comprehensive income for the 18 month period

Loss for the 18 month period
-
(1,969,112)
(1,969,112)
Total comprehensive income for the 18 month period
-
(1,969,112)
(1,969,112)


At 31 December 2024
1
(4,477,617)
(4,477,616)



STATEMENT OF CHANGES IN EQUITY
FOR THE 53 WEEK PERIOD ENDED 1 JULY 2023


Called up share capital
Profit and loss account
Total equity

£
£
£

At 26 June 2022
1
(2,637,806)
(2,637,805)


Comprehensive income for the period

Profit for the period
-
129,301
129,301
Total comprehensive income for the period
-
129,301
129,301


At 1 July 2023
1
(2,508,505)
(2,508,504)


The notes on pages 17 to 33 form part of these financial statements.

Page 16

 
HYPNOS CONTRACT BEDS LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE 18 MONTH PERIOD ENDED 31 DECEMBER 2024

1.


General information

Hypnos Contract Beds Limited is a company limited by shares, incorporated in England and Wales. The address of the registered office is Hypnos Limited, Longwick Road, Princes Risborough, Buckinghamshire, HP27 9RS.
The company specialises in manufacture of beds and furniture.

2.Accounting policies

 
2.1

Basis of preparation of financial statements

The financial statements have been prepared under the historical cost convention and in accordance with Financial Reporting Standard 102, the Financial Reporting Standard applicable in the UK and the Republic of Ireland and the Companies Act 2006 and on the assumption that the company is a going concern.
The preparation of financial statements in compliance with FRS 102 requires the use of certain critical accounting estimates. It also requires management to exercise judgment in applying the Company's accounting policies (see note 3).
The company previously maintained its accounting records on a weekly basis. However, the Company has elected to extend the year end to 31 December 2024 therefore forming an 18 month period.
The following principal accounting policies have been applied:

 
2.2

Financial Reporting Standard 102 - reduced disclosure exemptions

The Company has taken advantage of the following disclosure exemptions in preparing these financial statements, as permitted by the FRS 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland":
the requirements of Section 7 Statement of Cash Flows;
the requirements of Section 3 Financial Statement Presentation paragraph 3.17(d);
the requirements of Section 33 Related Party Disclosures paragraph 33.7.

This information is included in the consolidated financial statements of Keen & Toms Holdings Limited as at 31 December 2024 and these financial statements may be obtained from Companies House, Crown Way, Maindy, Cardiff, CF14 3UZ.

Page 17

 
HYPNOS CONTRACT BEDS LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE 18 MONTH PERIOD ENDED 31 DECEMBER 2024

2.Accounting policies (continued)

 
2.3

Going concern

The financial statements are prepared on a going concern basis, despite the balance sheet showing net current liabilities of £4,418,148 (2023 - £2,675,695). The directors note that the company is trading adequately and has sufficient working capital and other finance available to continue trading for a period of not less than 12 months from the date of signing these financial statements. As such, the directors believe that there are no significant uncertainties in their assessment of whether the business is a going concern and therefore have prepared the accounts on a going concern basis.
Furthermore, the directors of the company's fellow subsidiaries have provided an undertaking that they will not seek repayment of the amount due to them until such time that the company has sufficient funds to do so and will continue to support the company for the foreseeable future, and specifically for a period not less than 12 months from the date of signing of these financial statements, such that the company will be able to meet its liabilities as they fall due.

 
2.4

Revenue

Revenue is recognised to the extent that it is probable that the economic benefits will flow to the Company and the revenue can be reliably measured. Revenue is measured as the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes. The following criteria must also be met before revenue is recognised:

Sale of goods

Revenue from the sale of goods is recognised when all of the following conditions are satisfied:
the Company has transferred the significant risks and rewards of ownership to the buyer;
the Company retains neither continuing managerial involvement to the degree usually associated with ownership nor effective control over the goods sold;
the amount of revenue can be measured reliably;
it is probable that the Company will receive the consideration due under the transaction; and
the costs incurred or to be incurred in respect of the transaction can be measured reliably.

Rendering of services

Revenue from a contract to provide services is recognised in the period in which the services are provided in accordance with the stage of completion of the contract when all of the following conditions are satisfied:
the amount of revenue can be measured reliably;
it is probable that the Company will receive the consideration due under the contract;
the stage of completion of the contract at the end of the reporting period can be measured reliably; and
the costs incurred and the costs to complete the contract can be measured reliably.

Revenue is recognised when performance obligations are met and where there is no product risk or credit risk even if the customer chooses to delay delivery of goods.

Page 18

 
HYPNOS CONTRACT BEDS LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE 18 MONTH PERIOD ENDED 31 DECEMBER 2024

2.Accounting policies (continued)

 
2.5

Tangible fixed assets

Tangible fixed assets under the cost model are stated at historical cost less accumulated depreciation and any accumulated impairment losses. Historical cost includes expenditure that is directly attributable to bringing the asset to the location and condition necessary for it to be capable of operating in the manner intended by management.

The Company adds to the carrying amount of an item of fixed assets the cost of replacing part of such an item when that cost is incurred, if the replacement part is expected to provide incremental future benefits to the Company. The carrying amount of the replaced part is derecognised. Repairs and maintenance are charged to the Statement of comprehensive income during the period in which they are incurred.

Depreciation is charged so as to allocate the cost of assets less their residual value over their estimated useful lives.

Depreciation is provided on the following basis:

Plant and machinery
-
20%
straight line
Motor vehicles
-
25%
straight line
Fixtures and fittings
-
20%
straight line

The assets' residual values, useful lives and depreciation methods are reviewed, and adjusted prospectively if appropriate, or if there is an indication of a significant change since the last reporting date.

Gains and losses on disposals are determined by comparing the proceeds with the carrying amount and are recognised in the Statement of comprehensive income.

 
2.6

Stocks

Stocks are stated at the lower of cost and net realisable value, being the estimated selling price less costs to complete and sell. Cost includes all direct costs and an appropriate proportion of fixed and variable overheads. Work in progress and finished goods include labour and attributable overheads.

At each reporting date, stocks are assessed for impairment. If stock is impaired, the carrying amount is reduced to its selling price less costs to complete and sell. The impairment loss is recognised immediately in the Statement of comprehensive income.

 
2.7

Debtors

Short-term debtors are measured at transaction price, less any impairment. Loans receivable are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method, less any impairment.

 
2.8

Cash and cash equivalents

Cash is represented by cash in hand and deposits with financial institutions repayable without penalty on notice of not more than 24 hours. Cash equivalents are highly liquid investments that mature in no more than three months from the date of acquisition and that are readily convertible to known amounts of cash with insignificant risk of change in value.

Page 19

 
HYPNOS CONTRACT BEDS LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE 18 MONTH PERIOD ENDED 31 DECEMBER 2024

2.Accounting policies (continued)

 
2.9

Financial instruments

The Company only enters into basic financial instruments transactions that result in the recognition of financial assets and liabilities like trade and other accounts receivable and payable, loans from banks and other third parties and loans to and from related parties.
Debt instruments (other than those wholly repayable or receivable within one year), including loans and other accounts receivable and payable, are initially measured at present value of the future cash flows and subsequently at amortised cost using the effective interest method. Debt instruments that are payable or receivable within one year, typically trade payables or receivables, are measured, initially and subsequently, at the undiscounted amount of the cash or other consideration expected to be paid or received. However if the arrangements of a short-term instrument constitute a financing transaction, like the payment of a trade debt deferred beyond normal business terms or financed at a rate of interest that is not a market rate or in case of an out-right short-term loan not at market rate, the financial asset or liability is measured, initially, at the present value of the future cash flow discounted at a market rate of interest for a similar debt instrument and subsequently at amortised cost.
Financial assets that are measured at cost and amortised cost are assessed at the end of each reporting period for objective evidence of impairment. If objective evidence of impairment is found, an impairment loss is recognised in the Statement of comprehensive income.
For financial assets measured at amortised cost, the impairment loss is measured as the difference between an asset's carrying amount and the present value of estimated cash flows discounted at the asset's original effective interest rate. If a financial asset has a variable interest rate, the discount rate for measuring any impairment loss is the current effective interest rate determined under the contract.
For financial assets measured at cost less impairment, the impairment loss is measured as the difference between an asset's carrying amount and best estimate of the recoverable amount, which is an approximation of the amount that the Company would receive for the asset if it were to be sold at the reporting date.
Financial assets and liabilities are offset and the net amount reported in the Statement of financial position when there is an enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

 
2.10

Creditors

Short-term creditors are measured at the transaction price. Other financial liabilities, including bank loans, are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method.

Page 20

 
HYPNOS CONTRACT BEDS LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE 18 MONTH PERIOD ENDED 31 DECEMBER 2024

2.Accounting policies (continued)

 
2.11

Foreign currency translation

Functional and presentation currency

The Company's functional and presentational currency is GBP.

Transactions and balances

Foreign currency transactions are translated into the functional currency using the spot exchange rates at the dates of the transactions.

At each period end foreign currency monetary items are translated using the closing rate. Non-monetary items measured at historical cost are translated using the exchange rate at the date of the transaction and non-monetary items measured at fair value are measured using the exchange rate when fair value was determined.

Foreign exchange gains and losses resulting from the settlement of transactions and from the translation at period-end exchange rates of monetary assets and liabilities denominated in foreign currencies are recognised in the Statement of comprehensive income except when deferred in other comprehensive income as qualifying cash flow hedges.

Foreign exchange gains and losses that relate to borrowings and cash and cash equivalents are presented in the Statement of comprehensive income within 'finance income or costs'. All other foreign exchange gains and losses are presented in the Statement of comprehensive income within 'other operating income'.

 
2.12

Finance costs

Finance costs are charged to the Statement of comprehensive income over the term of the debt using the effective interest method so that the amount charged is at a constant rate on the carrying amount. Issue costs are initially recognised as a reduction in the proceeds of the associated capital instrument.

 
2.13

Pensions

Defined contribution pension plan
The Company operates a defined contribution plan for its employees. A defined contribution plan is a pension plan under which the Company pays fixed contributions into a separate entity. Once the contributions have been paid the Company has no further payments obligations.
The contributions are recognised as an expense in the Statement of comprehensive income when they fall due. Amounts not paid are shown in accruals as a liability in the Statement of financial position. The assets of the plan are held separately from the Company in independently administered funds.

Page 21

 
HYPNOS CONTRACT BEDS LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE 18 MONTH PERIOD ENDED 31 DECEMBER 2024

2.Accounting policies (continued)

 
2.14

Provisions for liabilities

Provisions are made where an event has taken place that gives the Company a legal or constructive obligation that probably requires settlement by a transfer of economic benefit, and a reliable estimate can be made of the amount of the obligation.
Provisions are charged as an expense to profit or loss in the year that the Company becomes aware of the obligation, and are measured at the best estimate at the reporting date of the expenditure required to settle the obligation, taking into account relevant risks and uncertainties.
When payments are eventually made, they are charged to the provision carried in the Statement of financial position.

 
2.15

Current and deferred taxation

The tax expense for the 18 month period comprises current and deferred tax.Tax is recognised in the statement of comprehensive income except that a charge attributable to an item of income and expense recognised as other comprehensive income or to an item recognised directly in equity is also recognised in other comprehensive income or directly in equity respectively.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date in the countries where the Company operates and generates income.

Deferred tax balances are recognised in respect of all timing differences that have originated but not reversed by the reporting date, except that:
The recognition of deferred tax assets is limited to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits; and
Any deferred tax balances are reversed if and when all conditions for retaining associated tax allowances have been met.

Deferred tax balances are not recognised in respect of permanent differences except in respect of business combinations, when deferred tax is recognised on the differences between the fair values of assets acquired and the future tax deductions available for them and the differences between the fair values of liabilities acquired and the amount that will be assessed for tax. Deferred tax is determined using tax rates and laws that have been enacted or substantively enacted by the reporting date.


 
2.16

Borrowing costs

All borrowing costs are recognised in the Statement of comprehensive income in the 18 month period in which they are incurred.

 
2.17

Exceptional items

Exceptional items are transactions that fall within the ordinary activities of the Company but are presented separately due to their size or incidence.

Page 22

 
HYPNOS CONTRACT BEDS LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE 18 MONTH PERIOD ENDED 31 DECEMBER 2024

3.


Judgments in applying accounting policies and key sources of estimation uncertainty

The directors do not consider any of the estimates or judgements in relation to applying the accounting policies material to these financial statements. 


4.


Turnover

The whole of the turnover is attributable to the manufacture of beds and furniture.

Analysis of turnover by country of destination:

18 month period ended
31 December
53 week period ended
1 July
2024
2023
£
£

United Kingdom
11,715,444
17,984,123

Rest of Europe
1,730,635
1,998,947

Rest of the world
823,189
113,211

14,269,268
20,096,281



5.


Other operating income

18 month period ended
31 December
53 week period ended
1 July
2024
2023
£
£

Intercompany management income
-
260,000

-
260,000


Page 23

 
HYPNOS CONTRACT BEDS LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE 18 MONTH PERIOD ENDED 31 DECEMBER 2024

6.


Operating (loss)/profit

The operating (loss)/profit is stated after charging:

18 month period ended
31 December
53 week period ended
1 July
2024
2023
£
£

Depreciation of tangible fixed assets
122,159
128,215

Exchange differences
33,597
(4,836)

Other operating lease rentals
233,300
289,720


7.


Auditors' remuneration

During the period, the Company obtained the following services from the Company's auditors:


18 month period ended 31 December
53 week period ended
1 July
2024
2023
£
£

Fees payable to the Company's auditors for the audit of the Company's financial statements
20,000
18,980


The Company has taken advantage of the exemption not to disclose amounts paid for non-audit services as these are disclosed in the consolidated accounts of the parent Company.




Page 24

 
HYPNOS CONTRACT BEDS LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE 18 MONTH PERIOD ENDED 31 DECEMBER 2024

8.


Employees

Staff costs, including directors' remuneration, were as follows:


18 month period ended
31 December
53 week period ended
1 July
2024
2023
£
£

Wages and salaries
2,056,619
3,801,654

Social security costs
234,912
386,545

Cost of defined contribution scheme
101,769
145,092

2,393,300
4,333,291


During the period, staff were remunerated through Hypnos Limited and the relevant costs recharged.

The average monthly number of employees, including the directors, during the 18 month period was as follows:


18 month
 period ended
     31 December
53 week period ended
        1 July
        2024
        2023
            No.
            No.







Administration
27
104



Production
30
20

57
124


9.


Directors' remuneration

During the period the directors were remunerated through Hypnos Limited. Only the directors are considered to be key management and therefore the remuneration of key management is as disclosed for directors in Hypnos Limited and Keen & Toms Holdings Limited. No apportionment has been deemed necessary.

Page 25

 
HYPNOS CONTRACT BEDS LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE 18 MONTH PERIOD ENDED 31 DECEMBER 2024

10.


Interest payable and similar expenses

18 month period ended
31 December
53 week period ended
1 July
2024
2023
£
£


Other loan interest payable
607
1,230

607
1,230


11.


Taxation


18 month period ended
31 December
53 week period ended
1 July
2024
2023
£
£



Total current tax
-
-

Tax on (loss)/profit on ordinary activities
 
-
 
-
Page 26

 
HYPNOS CONTRACT BEDS LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE 18 MONTH PERIOD ENDED 31 DECEMBER 2024
 
11.Taxation (continued)


Factors affecting tax charge for the period

The tax assessed for the period is higher than (2023 - lower than) the standard rate of corporation tax in the UK of 25% (2023 - 19%). The differences are explained below:

18 month period ended
31 December
53 week period ended
1 July
2024
2023
£
£


(Loss)/profit on ordinary activities before tax
(1,969,112)
129,301


(Loss)/profit on ordinary activities multiplied by standard rate of corporation tax in the UK of 25% (2023 - 19%)
(492,278)
24,567

Effects of:


Expenses not deductible for tax purposes, other than goodwill amortisation and impairment
845
643

Decelerated / (accelerated) capital allowances
44,970
(25,210)

Other timing differences leading to an increase (decrease) in taxation
152
-

Unrelieved tax losses carried forward
446,311
-

Total tax charge for the period
-
-


Factors that may affect future tax charges

Future tax charges are anticipated to be affected by the utilisation of losses carried forward amounting to £1,836,044 (period ended 1 July 2023 - £50,190). A deferred tax asset has not been recognised in respect of these losses due to uncertainty over the timing of the future utilisation of the losses. There is no expiry date of timing difference of unused tax losses.
There were no other factors that may affect future tax charges.

Page 27

 
HYPNOS CONTRACT BEDS LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE 18 MONTH PERIOD ENDED 31 DECEMBER 2024

12.


Exceptional items

18 month period ended
31 December
53 week period ended
1 July
2024
2023
£
£


Restructuring costs
1,445,145
150,947

Intercompany write off
23,274
-

1,468,419
150,947


13.


Tangible fixed assets







Plant and machinery
Motor vehicles
Fixtures and fittings
Total

£
£
£
£



Cost


At 2 July 2023
419,673
-
1,026,291
1,445,964


Additions
-
34,500
-
34,500


Disposals
(419,673)
(34,500)
(1,026,291)
(1,480,464)



At 31 December 2024

-
-
-
-





At 2 July 2023
319,456
-
885,809
1,205,265


Charge for the 18 month period on owned assets
22,263
-
92,741
115,004


Charge for the 18 month period on financed assets
7,155
-
-
7,155


Disposals
(348,874)
-
(978,550)
(1,327,424)



At 31 December 2024

-
-
-
-



Net book value



At 31 December 2024
-
-
-
-



At 1 July 2023
100,217
-
140,482
240,699

Page 28

 
HYPNOS CONTRACT BEDS LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE 18 MONTH PERIOD ENDED 31 DECEMBER 2024

           13.Tangible fixed assets (continued)

The net book value of assets held under finance leases or hire purchase contracts, included above, are as follows:


31 December
1 July
2024
2023
£
£



Plant and machinery
-
31,932

-
31,932


14.


Stocks

31 December
1 July
2024
2023
£
£

Raw materials and consumables
-
142,610

Finished goods and goods for resale
-
282,233

-
424,843



15.


Debtors

31 December
1 July
2024
2023
£
£


Trade debtors
773,336
1,575,521

Amounts owed by group undertakings
772,931
570,025

Other debtors
15,780
-

Prepayments and accrued income
655,410
223,958

2,217,457
2,369,504


Page 29

 
HYPNOS CONTRACT BEDS LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE 18 MONTH PERIOD ENDED 31 DECEMBER 2024

16.


Cash and cash equivalents

31 December
1 July
2024
2023
£
£

Cash at bank and in hand
1,174,598
441,942

Less: bank overdrafts and invoice discounting
(105,305)
(433,629)

1,069,293
8,313



17.


Creditors: Amounts falling due within one year

31 December
1 July
2024
2023
£
£

Bank overdrafts and invoice discounting
105,305
433,629

Trade creditors
540,860
1,807,917

Amounts owed to group undertakings
5,005,646
1,984,534

Other taxation and social security
226,188
189,901

Obligations under finance lease and hire purchase contracts
10,460
10,631

Other creditors
1,789,838
1,346,938

Accruals and deferred income
131,906
138,434

7,810,203
5,911,984


The invoice discounting included above is secured by a fixed and floating charge over the undertaking and all property and assets present and future, including goodwill, book debts, uncalled capital, buildings, fixtures and fixed plant & machinery.
Obligations under finance leases are secured against the assets leased.


18.


Creditors: Amounts falling due after more than one year

31 December
1 July
2024
2023
£
£

Net obligations under finance leases and hire purchase contracts
3,440
17,480

3,440
17,480


Obligations under finance leases are secured against the assets leased.

Page 30

 
HYPNOS CONTRACT BEDS LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE 18 MONTH PERIOD ENDED 31 DECEMBER 2024

19.


Hire purchase and finance leases


Minimum lease payments under hire purchase fall due as follows:

31 December
1 July
2024
2023
£
£


Within one year
10,460
10,631

Between 1-5 years
3,440
17,480

13,900
28,111


20.


Financial instruments

31 December
1 July
2024
2023
£
£

Financial assets


Financial assets that are debt instruments measured at amortised cost
1,562,047
2,145,546


Financial liabilities


Financial liabilities measured at amortised cost
7,452,109
5,583,649


Financial assets that are debt instruments measured at amortised cost comprise trade debtors, amounts owed by group undertakings, and other debtors.


Financial liabilities measured at amortised cost comprise bank overdrafts, trade creditors, amounts owed to group undertakings, other creditors, and obligations under finance lease and hire purchase contracts.


21.


Deferred taxation






2024


£






At beginning of year
56,028



At end of year
56,028

Page 31

 
HYPNOS CONTRACT BEDS LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE 18 MONTH PERIOD ENDED 31 DECEMBER 2024
 
21.Deferred taxation (continued)

The provision for deferred taxation is made up as follows:

31 December
1 July
2024
2023
£
£


Accelerated capital allowances
56,028
56,028

56,028
56,028


22.


Share capital

31 December
1 July
2024
2023
£
£
Allotted, called up and fully paid



1 Ordinary share of £1
1
1



23.


Reserves

Profit and loss account

Profit and loss account includes all current and prior period retained profits and losses.


24.


Contingent liabilities

There is an unlimited cross guarantee originally dated 26 August 2008 and updated due to new subsidiaries between the company, Keen & Toms Partnership Limited, Hypnos Limited, Keen & Toms Holdings Limited, The Furniture Recycling Company Limited, The Sheen Bed Company Limited, Keen & Able Limited and Imperial Sleep Limited over any overdraft or invoice discounting borrowings from their bankers of the respective companies. The company entered into a debenture with its bankers on 13 August 2008 providing security over all assets of the company. The total amount of borrowings in the group is £5,041,358 at 31 December 2024 (1 July 2023 -  £4,095,624)


25.


Pension commitments

The company operates a defined contribution pension scheme. The assets of the scheme are held separately from those of the company in an independently administered fund. The pension cost charge represents contributions payable by the company to the fund and amounted to £101,769 for the 18 month period. (53 week period ended 1 July 2023 - £145,092).

Page 32

 
HYPNOS CONTRACT BEDS LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE 18 MONTH PERIOD ENDED 31 DECEMBER 2024

26.


Commitments under operating leases

At 31 December 2024 the Company had future minimum lease payments due under non-cancellable operating leases for each of the following periods:

31 December
1 July
2024
2023
£
£



Not later than 1 year
12,304
202,502

Later than 1 year and not later than 5 years
-
56,054

12,304
258,556


27.


Related party transactions

The company has taken advantage allowed by Financial Reporting Standard 102 not to disclose any transactions with wholly owned members of the group. 
 
During the period the company made sales to a director which are at the same prices as the staff sales scheme. In aggregate these are £Nil (period ended 1 July 2023 - £1,610). The outstanding balances at period end aggregated to £Nil at 31 December 2024 (1 July 2023 - £Nil).


28.


Post balance sheet events

Subsequent to the year end, the company refinanced its existing borrowing facilities. The refinancing replaced the previous loan agreement with new facilities on improved terms. This event occurred after the year end and does not affect the amounts recognised in the financial statements.
There are no other subsequent events that require disclosure or adjustments to the financial statements.


29.


Ultimate parent undertaking and controlling party

The immediate parent company is Keen & Toms Partnership Limited. The ultimate parent company is Keen & Toms Holdings Limited, a company registered in England and Wales. In the view of the directors there is no ultimate controlling party.
Consolidated accounts for Keen & Toms Holdings Limited are available at Companies House, Crown Way, Maindy, Cardiff, CF14 3UZ. This is the only company in the group which prepares consolidated accounts.

 
Page 33